TEZAPSIDIS NIKOLAOS has a total of 11 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States, Canada and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are DEL MAR PHARMACEUTICALS, PHARMAGENE LAB LIMITED and AROG PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Canada | 1 | |
#3 | Republic of Korea | 1 | |
#4 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Measuring microorganism processes | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Tezapsidis Nikolaos | 11 |
#2 | Smith Mark | 7 |
#3 | Greco Steven J | 5 |
#4 | Greco Steven | 3 |
Publication | Filing date | Title |
---|---|---|
US2013183309A1 | Fragments, Mutants and Chimeric Fusion Proteins of Leptin For Treating Alzheimer's Disease | |
US2012231457A1 | Compositions and methods for assessing a genetic risk of developing late-onset alzheimer's disease (load) | |
US2007066527A1 | Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology |